Fair Value Measurements (Details) (USD $) | Jun. 30, 2014 | Dec. 31, 2013 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Open-end funds | $296,400,000 | $450,400,000 |
Securities and derivatives owned by partnership (Note 5) | 147,346,000 | 34,047,000 |
Carrying value of long-term debt | 92,115,000 | 92,115,000 |
Long-term debt fair value | 103,300,000 | 104,400,000 |
Payment obligation associated with acquisition | 1,700,000 | 3,400,000 |
Payment obligation fair value | 1,600,000 | 3,300,000 |
Recurring | Fair Value | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Cash and cash equivalents | 21,256,000 | 1,752,000 |
Investment securities (Note 3) | 321,134,000 | 472,241,000 |
Securities and derivatives owned by partnership (Note 5) | 143,521,000 | 29,299,000 |
Securities sold but not yet purchased by partnership (Note 5) | -11,090,000 | -10,726,000 |
Total | 474,821,000 | 492,566,000 |
Recurring | Fair Value | Global Growth | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 168,594,000 | 225,892,000 |
Recurring | Fair Value | U.S. Growth | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 63,545,000 | 97,936,000 |
Recurring | Fair Value | Value | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 15,223,000 | 9,959,000 |
Recurring | Fair Value | Alternative | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 40,416,000 | 37,436,000 |
Recurring | Fair Value | Fixed Income/High Yield | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 31,389,000 | 99,260,000 |
Recurring | Fair Value | Other | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 1,758,000 | 1,545,000 |
Recurring | Fair Value | Total Funds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 320,925,000 | 472,028,000 |
Recurring | Fair Value | Common stock | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 209,000 | 213,000 |
Securities and derivatives owned by partnership (Note 5) | 88,711,000 | 29,149,000 |
Securities sold but not yet purchased by partnership (Note 5) | -2,367,000 | -10,185,000 |
Recurring | Fair Value | Exchange-traded funds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities sold but not yet purchased by partnership (Note 5) | ' | -485,000 |
Recurring | Fair Value | Common stocks - owned by partnership | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities sold but not yet purchased by partnership (Note 5) | -8,253,000 | ' |
Recurring | Fair Value | Exchange-traded put option contracts | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 686,000 | 150,000 |
Recurring | Fair Value | U.S. Growth | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities sold but not yet purchased by partnership (Note 5) | -420,000 | ' |
Recurring | Fair Value | Exchange-traded call option contracts | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities sold but not yet purchased by partnership (Note 5) | -50,000 | -56,000 |
Recurring | Fair Value | Preferred stocks | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 5,843,000 | ' |
Recurring | Fair Value | Convertible bonds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 40,376,000 | ' |
Recurring | Fair Value | Corporate bonds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 458,000 | ' |
Recurring | Fair Value | Sovereign bonds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 2,334,000 | ' |
Recurring | Fair Value | Short term investments | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 5,113,000 | ' |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Cash and cash equivalents | 21,256,000 | 1,752,000 |
Investment securities (Note 3) | 321,134,000 | 472,241,000 |
Securities and derivatives owned by partnership (Note 5) | 71,087,000 | 29,299,000 |
Securities sold but not yet purchased by partnership (Note 5) | -11,090,000 | -10,726,000 |
Total | 402,387,000 | 492,566,000 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Global Growth | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 168,594,000 | 225,892,000 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | U.S. Growth | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 63,545,000 | 97,936,000 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Value | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 15,223,000 | 9,959,000 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Alternative | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 40,416,000 | 37,436,000 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Fixed Income/High Yield | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 31,389,000 | 99,260,000 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Other | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 1,758,000 | 1,545,000 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Total Funds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 320,925,000 | 472,028,000 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Common stock | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 209,000 | 213,000 |
Securities and derivatives owned by partnership (Note 5) | 62,280,000 | 29,149,000 |
Securities sold but not yet purchased by partnership (Note 5) | -2,367,000 | -10,185,000 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Exchange-traded funds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities sold but not yet purchased by partnership (Note 5) | ' | -485,000 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Common stocks - owned by partnership | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities sold but not yet purchased by partnership (Note 5) | -8,253,000 | ' |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Exchange-traded put option contracts | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 686,000 | 150,000 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | U.S. Growth | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities sold but not yet purchased by partnership (Note 5) | -420,000 | ' |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Exchange-traded call option contracts | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities sold but not yet purchased by partnership (Note 5) | -50,000 | -56,000 |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Preferred stocks | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 3,008,000 | ' |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Convertible bonds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 0 | ' |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Corporate bonds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 0 | ' |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Sovereign bonds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 0 | ' |
Recurring | Quoted Prices in Active Markets for Identical Assets and Liabilities (Level 1) | Short term investments | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 5,113,000 | ' |
Recurring | Significant Other Observable Inputs (Level 2) | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Cash and cash equivalents | 0 | 0 |
Investment securities (Note 3) | 0 | 0 |
Securities and derivatives owned by partnership (Note 5) | 72,434,000 | 0 |
Securities sold but not yet purchased by partnership (Note 5) | 0 | 0 |
Total | 72,434,000 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Global Growth | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | U.S. Growth | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Value | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Alternative | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Fixed Income/High Yield | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Other | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Total Funds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Common stock | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Investment securities (Note 3) | 0 | 0 |
Securities and derivatives owned by partnership (Note 5) | 26,431,000 | 0 |
Securities sold but not yet purchased by partnership (Note 5) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Exchange-traded funds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities sold but not yet purchased by partnership (Note 5) | ' | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Common stocks - owned by partnership | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities sold but not yet purchased by partnership (Note 5) | 0 | ' |
Recurring | Significant Other Observable Inputs (Level 2) | Exchange-traded put option contracts | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | U.S. Growth | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities sold but not yet purchased by partnership (Note 5) | 0 | ' |
Recurring | Significant Other Observable Inputs (Level 2) | Exchange-traded call option contracts | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities sold but not yet purchased by partnership (Note 5) | 0 | 0 |
Recurring | Significant Other Observable Inputs (Level 2) | Preferred stocks | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 2,835,000 | ' |
Recurring | Significant Other Observable Inputs (Level 2) | Convertible bonds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 40,376,000 | ' |
Recurring | Significant Other Observable Inputs (Level 2) | Corporate bonds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 458,000 | ' |
Recurring | Significant Other Observable Inputs (Level 2) | Sovereign bonds | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | 2,334,000 | ' |
Recurring | Significant Other Observable Inputs (Level 2) | Short term investments | ' | ' |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ' | ' |
Securities and derivatives owned by partnership (Note 5) | $0 | ' |